ArticleBlood advances2025
Frontline allo-SCT in MRD-negative, intermediate-risk AML.
Eduardo Rodríguez-Arbolí et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleBlood advances2025
Eduardo Rodríguez-Arbolí et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.